Omega-3 fatty acids, specifically DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), are the most studied dietary supplements for brain health with a plausible biological mechanism. DHA is a structural component of neuronal cell membranes, concentrated especially in the brain’s synaptic terminals. EPA has anti-inflammatory properties relevant to neuroinflammation. Whether supplementation in people with adequate dietary omega-3 intake produces additional cognitive benefit is less clear than the basic biology would suggest.
The Role of DHA in Brain Structure
The human brain is approximately 60% fat by dry weight, and DHA makes up a substantial proportion of the polyunsaturated fat in neuronal membranes, particularly in the synaptic terminals where neurotransmitter release occurs. DHA in cell membranes affects membrane fluidity, which influences receptor function, ion channel activity, and neurotransmitter signaling efficiency.
DHA accumulates in the brain primarily during fetal development and early childhood, which is why DHA is supplemented in infant formula and why prenatal omega-3 status matters for neurodevelopmental outcomes. In adults, brain DHA turnover is slow, and the relationship between dietary DHA and brain DHA concentration is not as direct as in the developing brain.
Plasma omega-3 levels correlate with brain volume in older adults. A 2014 study found that older women with higher plasma omega-3 levels had larger brain volumes on MRI compared to those with lower levels, with the association strongest for DHA. Whether this reflects causality or shared lifestyle factors is not established.
What Controlled Trials Actually Show
The promise from observational and mechanistic studies has not consistently translated into benefit in randomized controlled trials, particularly in cognitively healthy adults with adequate baseline omega-3 intake.
In people with MCI or early dementia: A 2006 Cochrane review and subsequent meta-analyses found modest benefits for certain cognitive domains in people with mild cognitive impairment (MCI) or early Alzheimer’s disease, particularly for episodic memory. The effects were small in absolute terms.
In healthy adults: Trials of omega-3 supplementation in cognitively healthy adults with normal omega-3 status generally do not show significant cognitive improvements. The ORIGIN trial and ASCEND trial, large-scale cardiovascular outcome trials, found no cognitive benefit from omega-3 supplementation in healthy adults.
In populations with low baseline intake: People with chronically low omega-3 intake, common in Western dietary patterns where fish consumption is low, show the greatest response to supplementation. Those already consuming adequate seafood or with high plasma DHA see little additional benefit from supplementation.
EPA and Neuroinflammation
EPA has weaker structural effects on brain tissue than DHA but is a precursor to anti-inflammatory eicosanoids that reduce neuroinflammation. Neuroinflammation is implicated in depression, cognitive decline, and neurodegenerative disease.
The evidence for EPA’s benefit is strongest in depression rather than in cognitive performance. A 2019 meta-analysis in Translational Psychiatry found that omega-3 supplementation reduced depressive symptoms, with EPA-dominant formulations outperforming DHA-dominant ones. This aligns with the anti-inflammatory mechanism hypothesis.
Practical Recommendations
Dietary sources first: Two to three servings of fatty fish per week (salmon, mackerel, sardines, anchovies, herring) provides approximately 2-3 grams of combined EPA and DHA, which represents adequate intake for most adults. Algae-based DHA is available for those who do not eat fish.
Supplementation for deficient populations: People who do not eat fish regularly and have documented low omega-3 status benefit more from supplementation than those with adequate intake. A dose of 1-2 grams of combined EPA+DHA daily is the range used in most clinical trials.
Form matters: Triglyceride form omega-3s (as found in natural fish oil) absorb better than ethyl ester forms when taken with food. Algae-based DHA provides the same DHA as fish-derived supplements without the fish.
What supplementation is unlikely to produce: A detectable cognitive boost in healthy adults who already eat fish regularly or have normal omega-3 status. The evidence base does not support this use.
For the overall picture of lifestyle factors that affect brain health, see Exercise and Brain Health: The BDNF Connection and Chronic Stress and Memory: What Cortisol Does to the Brain.
